Siemens' Peter Shen on Varian's Role in Cancer Care, AI, and Precision Therapy
About this episode
Peter Shen from Varian discusses the future of AI-driven oncology and its impact on cancer care.
Join me with Peter Shen from Varian (a Siemens Healthineers company) to discuss the future of AI-driven oncology. Discover how practical AI is transforming radiation treatment and reducing bottlenecks, strategies for precision therapy,survivorship, and the bipartisan Health Tech Investment Act potential impact. Don't forget to subscribe to our Substack: https://substack.com/@digitalhealthroundtable
More episodes of The Digital Health Roundtable
- Uber Health at Scale with Allison Marsh
- Untangling the Data Maze:: Evidently's Vision with Kalie Dove-Maguire MD
- Healthcare's Future with Philips: Shez Partovi MD, AI, and Integrated Diagnostics at HIMSS
- SVB’s Megan Scheffel on Bio-Hope, the 2026 Landscape, and Longevity
- Tectonic Shifts in 2026 with Shez Partovi of Philips
- Innovative Care Solutions with Garner's Physician Network :: CTO Michi Kono
Explore listener stats, chart rankings, contacts and more on the The Digital Health Roundtable podcast page.